Hepatitis C virus treatment as prevention among injecting drug users: who should we cure first?

Publisher： John Wiley & Sons Inc

E-ISSN： 1360-0443|110|6|975-983

ISSN： 0965-2140

Source： ADDICTION, Vol.110, Iss.6, 2015-06, pp. : 975-983

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The changing landscape of hepatitis C treatment—not ‘can we cure?’ but ‘who should we cure first?’ Is this an ethical approach?

By  

ADDICTION, Vol. 110, Iss. 6, 2015-06 ,pp. : 984-985

John Wiley & Sons Inc

Access to resources Recommend Favorite

The health consequences of injecting tablet preparations: foreign body pulmonary embolization and pulmonary hypertension among deceased injecting drug users

By  

ADDICTION, Vol. 110, Iss. 7, 2015-07 ,pp. : 1144-1151

John Wiley & Sons Inc

Access to resources Recommend Favorite

Explanations and expectations: drug narratives among young cannabis users in treatment

By  

SOCIOLOGY OF HEALTH & ILLNESS, Vol. 37, Iss. 6, 2015-07 ,pp. : 870-887

John Wiley & Sons Inc

Access to resources Recommend Favorite

Taking care of themselves: how long‐term injection drug users remain HIV and Hepatitis C free

By  

SOCIOLOGY OF HEALTH & ILLNESS, Vol. 37, Iss. 4, 2015-05 ,pp. : 626-641

John Wiley & Sons Inc

Access to resources Recommend Favorite

Estimating the number of people with hepatitis C virus who have ever injected drugs and have yet to be diagnosed: an evidence synthesis approach for Scotland

By  

ADDICTION, Vol. 110, Iss. 8, 2015-08 ,pp. : 1287-1300

John Wiley & Sons Inc

Access to resources Recommend Favorite